Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44351   clinical trials with a EudraCT protocol, of which   7378   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,351 result(s) found. Displaying page 488 of 2,218.
    «« First « Previous 484  485  486  487  488  489  490  491  492  Next» Last»»
    EudraCT Number: 2009-017380-42 Sponsor Protocol Number: M/34273/29 Start Date*: 2010-03-31
    Sponsor Name:ALMIRALL, S.A.
    Full Title: Efficacy and safety of three doses of aclidinium bromide compared to placebo and to an active comparator all administered twice daily by inhalation in patients with stable moderate and severe chron...
    Medical condition: Moderate to severe chronic obstructive pulmonary disease (COPD)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10009033 Chronic obstructive pulmonary disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-007353-12 Sponsor Protocol Number: FARM79BKPY Start Date*: 2007-05-29
    Sponsor Name:UNIVERSITA` DEGLI STUDI DI PARMA
    Full Title: METHOTREXATE AS STEROID-SPARING AGENT IN IDIOPATHIC RETROPERITONEAL FIBROSIS: A MULTICENTRE RANDOMISED CONTROLLED TRIAL
    Medical condition: Pazient affected by idiopathic retroperitoneal fibrosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10046587 Urinary tract obstruction NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-021988-32 Sponsor Protocol Number: LUMI/10/ZOF- HYP/001 Start Date*: 2010-09-27
    Sponsor Name:LUSOFARMACO
    Full Title: A multicentre, multinational, randomised, double-blind, pilot, ascending dose for non responder, parallel group study on the therapeutic efficacy and safety of o.d. Zofenopril 30 mg plus HCTZ 12.5 ...
    Medical condition: elderly subjects (age > 65 years) affected by Isolated Systolic Hypertension
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050591 LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-001074-27 Sponsor Protocol Number: TG-M-004 Start Date*: 2005-08-02
    Sponsor Name:ThromboGenics Ltd.
    Full Title: A Multi-Centre, Double-Blind, Placebo-Controlled, Ascending-Dose, Clinical Trial of Intra-venous Microplasmin Administration in Patients with Acute Ischemic Stroke
    Medical condition: Acute Ischemic Stroke
    Disease: Version SOC Term Classification Code Term Level
    8.1 10055221 Ischemic stroke LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) DE (Completed) AT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-007951-29 Sponsor Protocol Number: MA0826 Start Date*: 2009-02-23
    Sponsor Name:Herlev Hospital, Onkologisk Afd. R
    Full Title: Et fase II forsøg af neoadjuverende behandling med pegyleret liposomal doxorubicin (Caelyx®) og cyklofosfamid +/- trastuzumab med efterfølgende docetaxel til patienter med primær inoperabel og loko...
    Medical condition: Primær inoperabel og lokoregional avanceret cancer mammae (LABC)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10006201 Breast cancer stage III LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-016806-18 Sponsor Protocol Number: TAX-ERB2 Start Date*: 2010-12-09
    Sponsor Name:Klinik Löwenstein gGmbH
    Full Title: Multizentrische, randomisierte Phase II-Studie zur Therapie des lokal fortgeschrittenen oder metastasierten NSCLC im Stadium IV UICC 7 mit zwei unterschiedlichen Regimen von Cisplatin / Carboplatin...
    Medical condition: patients with advanced or metastatic NSCLC
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10029514 Non-small cell lung cancer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017582-29 Sponsor Protocol Number: OPERA-AF Start Date*: 2010-03-01
    Sponsor Name:CONSORZIO MARIO NEGRI SUD
    Full Title: Omega-3 fatty acids for Prevention of post-opERative Atrial fibrillation (OPERA)
    Medical condition: Patients scheduled for cardiac surgery
    Disease: Version SOC Term Classification Code Term Level
    9.1 10007541 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017587-16 Sponsor Protocol Number: 006117 Start Date*: 2010-12-02
    Sponsor Name:Barts Health NHS Trust
    Full Title: Treatment monitoring using FDG-PET/CT and FLT-PET/CT in patients with Hodgkin Lymphoma.
    Medical condition: Hodgkin Lymphoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-019441-26 Sponsor Protocol Number: P081210 Start Date*: Information not available in EudraCT
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: Adalimumab dans l’Arthrite Juvénile Idiopathique pour le traitement de l’UVéITE (étude ADJUVITE)
    Medical condition: Uvéite dans l'arthrite Juvénile Idiopathique
    Disease: Version SOC Term Classification Code Term Level
    8.1 10046851 Arthrite Idiopathique Juvénile PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019448-38 Sponsor Protocol Number: UREP-PREPENDO-2010 Start Date*: 2010-07-01
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)
    Full Title: Ensayo clínico, prospectivo, aleatorizado, comparativo, para determinar la eficacia y seguridad de dos protocolos para preparación endometrial en mujeres subsidiarias de transferencia de embriones.
    Medical condition: Preparación endometrial en mujeres subsdiarias de tranferencia de embriones
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019454-41 Sponsor Protocol Number: 0822-053 Start Date*: 2010-07-16
    Sponsor Name:Merck Sharp & Dohm Corp.
    Full Title: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) in the treatment of Men with Osteoporosis Treated with Vitamin D and Calcium
    Medical condition: osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10031282 Osteoporosis LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: LV (Completed) DK (Completed) GB (Completed) NL (Completed) EE (Completed) IT (Completed) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-000103-29 Sponsor Protocol Number: MM-PEG-08 Start Date*: 2008-02-21
    Sponsor Name:OSPEDALE POLICLINICO S. MATTEO
    Full Title: A single arm phase 2 study on the efficacy of Pegfilgrastim (Neulasta) after DCEP chemotherapy: a feasibility study in multiple myeloma patients eligible for autologous transplant.
    Medical condition: multiple myeloma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028228 Multiple myeloma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000106-37 Sponsor Protocol Number: 37.07.-92906 Start Date*: 2008-08-28
    Sponsor Name:Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital
    Full Title: Studies on the combined treatment using etanercept and ultraviolet B for patients with moderate to severe psoriasis vulgaris
    Medical condition: Psoriasis vulgaris (Plaque-Typ)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-000121-19 Sponsor Protocol Number: CapRI 2 Start Date*: 2008-08-11
    Sponsor Name:University of Heidelberg
    Full Title: A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either ...
    Medical condition: Patients with Resected Pancreatic Adenocarcinoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033608 Pancreatic cancer resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-019253-18 Sponsor Protocol Number: 113978 Start Date*: Information not available in EudraCT
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: A phase II, open-label, multicentre study to evaluate the safety and immunogenicity of GSK Biologicals’ DTPa-HBV-IPV/Hib-MenC-TT vaccine as a booster dose in children aged 12 to 18 months, previous...
    Medical condition: Booster immunization of healthy children in the second year of life against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, Haemophilus influenzae type b (Hib) and serogroup C meningoco...
    Disease:
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2010-019261-28 Sponsor Protocol Number: NN8555-3796 Start Date*: 2010-07-26
    Sponsor Name:Novo Nordisk A/S
    Full Title: A randomised, single-dose, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy of NNC 0142-0000-0002 in subjects with active rheumatoid arthritis
    Medical condition: Rheumatoid arthritis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10039073 Rheumatoid arthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-005432-32 Sponsor Protocol Number: 08.0113 Start Date*: 2009-06-02
    Sponsor Name:St. George's University of London (SGUL)
    Full Title: Effects of an Angiotensin Receptor Antagonist Candesartan versus a calcium channel blocker Amlodipine on Microvascular Rarefaction, Endothelial Dysfunction and Microalbuminuria in Essential Hyperte...
    Medical condition: Essential hypertension
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10004254 Benign essential hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-005452-24 Sponsor Protocol Number: KvL Start Date*: 2008-10-30
    Sponsor Name:Fertilitetsklinikken, Afsnit 455, Gynækologisk-Obstetrisk Afdeling, Hvidovre Hospital
    Full Title: Kort versus lang reagensglasbehandling. En prospektiv, konsekutiv og randomiseret sammenlignende undersøgelse.
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000371-15 Sponsor Protocol Number: xxx Start Date*: 2007-04-26
    Sponsor Name:no sponsor for this trial
    Full Title: Intraläsionelle Phospatidylcholin-Injektionen zur Reduktion von Körperfett: Halbseitenvergleichsstudie: Messung der subkutanen Fettschichtdicke mit dem Lipometer (Pilotstudie)
    Medical condition: Reithosen-Fettverteilungstyp an den Lateralseiten der Oberschenkel
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-003336-38 Sponsor Protocol Number: MED.RES.HOS.2008.01.SM. Start Date*: 2009-02-06
    Sponsor Name:Department of Medical Research
    Full Title: The effect of Amiloride and Spironolacton on renophysiological and cardiovascular parametres in healthy patients
    Medical condition: Hypertension
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 484  485  486  487  488  489  490  491  492  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jul 20 08:10:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA